Free Trial

BioSig Technologies Q4 2022 Earnings Report

BioSig Technologies logo
$1.34 +0.04 (+3.08%)
(As of 12/20/2024 05:45 PM ET)

BioSig Technologies EPS Results

Actual EPS
-$1.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioSig Technologies Revenue Results

Actual Revenue
$0.14 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioSig Technologies Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Wall Street Icon: “You must get on the right side of this thing” (Ad)

I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.

This market shakeup is going to be much more intense.

BioSig Technologies Earnings Headlines

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
See More BioSig Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioSig Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioSig Technologies and other key companies, straight to your email.

About BioSig Technologies

BioSig Technologies (NASDAQ:BSGM), together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

View BioSig Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings